Opler Mark G A, Yavorsky Christian, Daniel David G
Dr. Opler is Adjunct Assistant Professor at NYU School of Medicine and Chief Research Officer at MedAvante-ProPhase Inc. in New York, New York.
Dr. Yavorsky is Chief Scientific Officer and Clinical Director at Cronos Clinical Consulting in Lambertville, New Jersey.
Innov Clin Neurosci. 2017 Dec 1;14(11-12):77-81.
Rater training and the maintenance of the consistency of ratings are critical to ensuring reliability of study measures and sensitivity to changes in the course of a clinical trial. The Positive and Negative Syndrome Scale (PANSS) has been widely used in clinical trials of schizophrenia and other disorders and is considered the "gold standard" for assessment of antipsychotic treatment efficacy. The various features associated with training and calibration of this scale are complex, reflecting the intricacy and heterogeneity of the disorders that the PANSS is used to evaluate. In this article, the authors review the methods for ensuring reliability of the PANSS as well as a proposed trajectory for its use in the future. An overview of the current principles, implementation, technologies, and strategies for the best use of the PANSS; tips for how to achieve consistency among raters; and optimal training practices of this instrument are presented.
评分者培训以及评分一致性的维持对于确保研究测量的可靠性和对临床试验过程中变化的敏感性至关重要。阳性和阴性症状量表（PANSS）已广泛应用于精神分裂症和其他疾病的临床试验，被视为评估抗精神病药物治疗疗效的“金标准”。与该量表的培训和校准相关的各种特征很复杂，反映了PANSS用于评估的疾病的复杂性和异质性。在本文中，作者回顾了确保PANSS可靠性的方法以及其未来使用的建议轨迹。介绍了当前最佳使用PANSS的原则、实施、技术和策略概述；评分者之间达成一致性的技巧；以及该工具的最佳培训实践。
